Envision Healthcare Corporation (NYSE:EVHC) had its price objective decreased by Bank of America Corporation from $72.00 to $60.00 in a research report issued to clients and investors on Monday. The firm currently has a “buy” rating on the stock. Bank of America Corporation’s target price indicates a potential upside of 41.58% from the stock’s current price.
EVHC has been the topic of a number of other reports. BidaskClub raised Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a report on Saturday, June 17th. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Envision Healthcare Corporation in a report on Monday, July 24th. Zacks Investment Research raised Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 target price on the stock in a report on Tuesday, July 4th. Jefferies Group LLC set a $71.00 target price on Envision Healthcare Corporation and gave the stock a “buy” rating in a report on Thursday, August 24th. Finally, Royal Bank Of Canada lifted their target price on Envision Healthcare Corporation from $72.00 to $77.00 and gave the stock an “outperform” rating in a report on Tuesday, June 27th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $75.33.
Shares of Envision Healthcare Corporation (NYSE EVHC) opened at 42.38 on Monday. The company has a 50 day moving average of $47.48 and a 200 day moving average of $55.16. Envision Healthcare Corporation has a 52-week low of $42.27 and a 52-week high of $74.75. The stock’s market capitalization is $4.96 billion.
Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Monday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.75 by $0.04. The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a positive return on equity of 5.35% and a negative net margin of 7.35%. Envision Healthcare Corporation’s revenue was up 156.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.34 earnings per share. Analysts predict that Envision Healthcare Corporation will post $1.40 EPS for the current fiscal year.
Envision Healthcare Corporation declared that its Board of Directors has authorized a share buyback program on Monday, September 18th that authorizes the company to repurchase $250.00 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 4.5% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s management believes its stock is undervalued.
COPYRIGHT VIOLATION WARNING: This news story was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://stocknewstimes.com/2017/10/11/envision-healthcare-corporation-evhc-price-target-cut-to-60-00.html.
A number of institutional investors and hedge funds have recently modified their holdings of EVHC. Karp Capital Management Corp purchased a new position in Envision Healthcare Corporation in the 1st quarter worth about $632,000. Ameritas Investment Partners Inc. purchased a new position in Envision Healthcare Corporation in the 1st quarter worth about $172,000. Nordea Investment Management AB increased its stake in Envision Healthcare Corporation by 3.7% in the 1st quarter. Nordea Investment Management AB now owns 3,341 shares of the company’s stock worth $205,000 after purchasing an additional 120 shares in the last quarter. Prudential Financial Inc. increased its stake in Envision Healthcare Corporation by 6.8% in the 1st quarter. Prudential Financial Inc. now owns 161,045 shares of the company’s stock worth $9,875,000 after purchasing an additional 10,192 shares in the last quarter. Finally, Stifel Financial Corp increased its stake in Envision Healthcare Corporation by 35.0% in the 1st quarter. Stifel Financial Corp now owns 7,044 shares of the company’s stock worth $430,000 after purchasing an additional 1,825 shares in the last quarter.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.